VEGF, an efficient promoter of endothelial cell migration in angiogenesis, has been demonstrated to stimulate breast carcinoma invasion utilizing chemokine receptor C-X-C chemokine receptor type 4 (CXCR4) affinity toward stromal-derived factor 1 (SDF-1) (14). This evidence concerns the gene CXCR4 and breast carcinoma.